UFP Technologies, Inc.

NASDAQ:UFPT

Medical - Devices

Healthcare
$305.65 +4.44%

+$10.10 today

Market cap
$2.37B
Beta
1.10
P/E (TTM)
26.8
EPS (TTM)
$8.89
52W Low $173.86High $274.93

Volume 0.08M

Average 0.21M

UFPT Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

UFP Technologies, Inc.NASDAQ: UFPT

Deferred Revenue · Q2 FY2026 · quarter ended Jun 2026

Deferred revenue rises 4.2% from a year ago

Deferred revenue stood at $4.8M at the end of Q2 FY2026, up 4.2% from a year earlier and up 3.8% from the prior quarter. Over 3 fiscal years it compounded at -3.2% a year.

Context

  • Deferred revenue amounted to 0.7% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Deferred revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps rising in the next quarterly balance sheet after a +4.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$4.8M+3.8% QoQ
Last fiscal yearDec 2025
$4.24M-9.1% YoY
Year agoJun 2025
$4.61M+4.2% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.2%——
1 year-9.1%——
3-year CAGR-3.2%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
4.24M USD
Year-over-year change
-9.1%
4-year CAGR
-0.0%

Deferred Revenue vs competitors

How UFPT compares with its peers on the latest reported figures

  • UFPT's Jun 2026 deferred revenue of $4.8M is the 4th highest of the 11 companies compared; the peer median is $0.
  • Its year-over-year change of +4.2% is the 4th highest of 6, against a peer median of +10.3%.
  • Deferred revenue amounts to 0.7% of total assets for UFPT, versus a peer median of 0.0%.
UFPT Competitors Peer median
Deferred Revenue for UFPT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GEHCGE HealthCare Technologies Inc.Jun 2026$2.2B +11.2%—5.9%
IARTIntegra LifeSciences Holdings CorporationMar 2026$11.62M +10.3%+16.5%0.3%
ENOVEnovis CorporationApr 2026$6.08M +3.6%+22.2%0.2%
UFPTUFP Technologies, Inc.Jun 2026$4.8M +4.2%-3.2%0.7%
SSIISS Innovations International, Inc.Mar 2026$3.58M +91.5%+1125.2%4.0%
MDTMedtronic plcJul 2026$0 ——0.0%
ESTAEstablishment Labs Holdings Inc.Sep 2026$0 -100.0%-10.6%0.0%
CNMDCONMED CorporationMar 2026$0 ——0.0%
SIBNSI-BONE, Inc.Mar 2026$0 ——0.0%
KIDSOrthoPediatrics Corp.Mar 2026$0 ——0.0%
RXSTRxSight, Inc.Mar 2026$0 —+38.7%0.0%
Peer median (excluding UFPT) $0+10.3%+22.2%0.0%

Competitors are the stored peer set for UFPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents11.12M4.45M5.26M13.45M20.3M
Short-term Investments00000
Net Receivables39.38M55.12M65.75M89.66M88.22M
Inventory33.44M53.54M70.19M87.54M86.86M
Other Current Assets00000
Total Current Assets87.32M116.35M144.63M194.95M201M
Property, Plant & Equipment (Net)65.89M71.23M75.73M86.71M97.99M
Goodwill107.91M113.03M113.26M189.66M197.4M
Intangible Assets67.59M68.36M64.12M144.25M140.85M
Long-term Investments0006.81M6.93M
Tax Assets01.45M607K010.66M
Other Non-current Assets5.43M7.78M5.79M6.62M10.91M
Total Non-current Assets246.81M261.85M259.5M434.05M464.73M
Total Assets334.13M378.19M404.14M629M665.74M
Account Payables10.61M19.96M22.29M24.27M24.29M
Short-term Debt4M4M4M12.5M12.5M
Tax Payables909K1.68M0223K0
Deferred Revenue4.25M4.68M6.62M4.67M4.24M
Other Current Liabilities11.2M7.95M8.74M11.29M11.71M
Total Current Liabilities38.78M55.96M58.21M76.3M74.86M
Long-term Debt71M51M28M176.88M122.96M
Deferred Tax Liabilities3.26M448K428K3.3M19.87M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities19.52M22.39M20.59M17.34M10.18M
Total Non-current Liabilities100.9M84.69M59.84M209.94M167M
Total Liabilities139.69M140.65M118.05M286.24M241.86M
Common Stock75K76K76K77K77K
Retained Earnings160.81M202.6M247.52M306.5M374.81M
Accumulated OCI0(610K)268K(4.17M)3.71M
Other Stockholders Equity(0)0000
Minority Interest00000
Total Equity194.45M237.55M286.09M342.76M423.88M
Total Debt84.36M68.37M46.04M206.03M154.48M
Net Debt73.24M63.92M40.77M192.58M134.18M

UFP Technologies, Inc.

NASDAQ:UFPT

Intrinsic Alpha fair value

Locked

Current Price

$305.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.